Log In
Print this Print this


Also known as: PD01

  Manage Alerts
Collapse Summary General Information
Company Affiris AG
DescriptionVaccine that targets the alpha synuclein (SNCA) protein
Molecular Target Alpha synuclein (SNCA)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today